Ipatasertib: Phase II data

A double-blind, placebo-controlled, international Phase II trial in 253 patients with metastatic CRPC previously treated with docetaxel showed that once-daily 400 mg

Read the full 225 word article

How to gain access

Continue reading with a
two-week free trial.